Search
for
Sort by
Research 661–690 of 1000+
- Embryologic layers in dermatology: Developmental checkpoint disorders, diagnostic insight, and regenerative futures
- Applications of Platelet-rich Plasma in the Treatment of Dermatological Disorders
- Molecular Mechanisms Affecting Development of Animal Fibers and Some Studies on Goats
- Hair Loss in Children
- British Hair and Nail Society
- Cutaneous Lupus Erythematosus
- Use of chemotherapy during human pregnancy
- Anatomy and Physiology of the Skin
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Stem cell niches in mammals
- Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
- Drug-Induced Skin, Nail and Hair Disorders
- Adverse effects of common medications on male fertility
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Small molecules and small molecule drugs in regenerative medicine
- Differences in Perceptions of Beauty and Cosmetic Procedures Performed in Ethnic Patients
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- A Practical Guide to Scalp Disorders
- Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- Alopecia in Association with Malignancy: A Review
- Skin disease in pregnancy
- Defining the identity of mouse embryonic dermal fibroblasts
- Skin manifestations of chronic kidney disease
- Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes
- Skin diseases in consequence of endocrine alterations
- Trias of keratosis pilaris, ulerythema ophryogenes and 18p monosomy: Zouboulis syndrome
- Ppp2r2a Knockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55α, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Drug eruptions in dermatology